Lyra Therapeutics Inc (LYRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2017 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -16,306 | N/A | N/A | N/A |
| Depreciation Amortization | 27 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -205 | N/A | N/A | N/A |
| Other Working Capital | 2,114 | N/A | N/A | N/A |
| Other Operating Activity | 616 | 0 | 0 | 0 |
| Operating Cash Flow | $-13,754 | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -211 | N/A | N/A | N/A |
| Investing Cash Flow | $-211 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | 111 | N/A | N/A | N/A |
| Other Financing Activity | -226 | 0 | 0 | 0 |
| Financing Cash Flow | $-115 | $N/A | $N/A | $N/A |
| Beginning Cash Position | 24,217 | N/A | N/A | N/A |
| End Cash Position | 10,137 | N/A | N/A | N/A |
| Net Cash Flow | $-14,080 | $N/A | $N/A | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -13,754 | N/A | N/A | N/A |
| Capital Expenditure | -211 | N/A | N/A | N/A |
| Free Cash Flow | -13,965 | 0 | 0 | 0 |